` Comparison: 6L7A vs BSX - Alpha Spread

B
6L7A
vs
BSX

Over the past 12 months, 6L7A has underperformed BSX, delivering a return of 0% compared to the BSX's 27% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
6L7A
BSX
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

6L7A Intrinsic Value
HIDDEN
Show
BSX Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
B
Bellerophon Therapeutics Inc
F:6L7A
0.35 EUR
Boston Scientific Corp
NYSE:BSX
72.315 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
6L7A, BSX

6L7A
BSX
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
B
Bellerophon Therapeutics Inc
Revenue
Boston Scientific Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
6L7A, BSX

6L7A
BSX
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
B
Bellerophon Therapeutics Inc
F:6L7A
Boston Scientific Corp
NYSE:BSX
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

6L7A
0%
BSX
69%

Operating Margin

6L7A
-195.7%
BSX
19.9%

Net Margin

6L7A
-164.1%
BSX
14.4%

FCF Margin

6L7A
-218.8%
BSX
18.2%

ROE

6L7A
-166%
BSX
12.6%

ROA

6L7A
-105.2%
BSX
7%

ROIC

6L7A
7 788.3%
BSX
8.7%

ROCE

6L7A
-197.9%
BSX
11.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
6L7A, BSX

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
6L7A, BSX

Performance Gap Between 6L7A and BSX
HIDDEN
Show

Performance By Year
6L7A, BSX

Loading
6L7A
BSX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 6L7A to other stocks
ABT
Abbott Laboratories
Cheaper
vs 6L7A
ISRG
Intuitive Surgical Inc
Cheaper
vs 6L7A
SYK
Stryker Corp
Cheaper
vs 6L7A
MDT
Medtronic PLC
Cheaper
vs 6L7A
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett